Eris Therapeutics Private Limited, a amalgamated private limited company, was established on 30 July 2009 in Rajkot, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230GJ2009PTC057670. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Inderjeet Singh Negi (Director), Amit Indubhushan Bakshi (Director), Kaushal Kamlesh Shah (Director). Past directors included Sanjiv Dwarkanath Kaul, Rakesh Bhikhalal Shah, Himanshu Jayantbhai Shah. Its latest AGM occurred on 28 September 2020, with the balance sheet filed on 31 March 2020. It is based at Vision 2020, Sf-209, 150Ft Ring Road, Nr. Lijjat Papad, Plt-3-4,, Rajkot, Gujarat, 360007.
U24230GJ2009PTC057670
057670
30 July 2009
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Amalgamated
Explore comprehensive insights into Eris Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Inderjeet Singh Negi | Director | 25 Nov 2009 | Current |
| Amit Indubhushan Bakshi | Director | 30 Jul 2009 | Current |
| Kaushal Kamlesh Shah | Director | 25 Nov 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jul 2017 | Past |
| Pramod Abcsdd | Director | 07 Feb 2012 | Past |
| Pramod Abcsdd | Director | 06 Aug 2020 | Past |
| Pramod Abcsdd | Director | 06 Aug 2020 | Past |
| Pramod Abcsdd | Director | 25 Jul 2017 | Past |
| Pramod Abcsdd | Director | 25 Jul 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eris Therapeutics Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 57.58% increase in profit. The company's net worth dipped by a decrease of 1.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Eris Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Eris Therapeutics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eris Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Eris Therapeutics Private Limited last Annual general meeting of members was held on 28 Sep 2020 as per latest MCA records. was documented.
Progress on Eris Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Ahmedabad. was documented.
Progress on Inderjeet Singh Negi was appointed as a Director was appointed as a Director on 25 Nov 2009 & has been associated with this company since 16 years 1 month . was documented.
Progress on Kaushal Kamlesh Shah was appointed as a Director was appointed as a Director on 25 Nov 2009 & has been associated with this company since 16 years 1 month . was documented.
Progress on Amit Indubhushan Bakshi was appointed as a Director was appointed as a Director on 30 Jul 2009 & has been associated with this company since 16 years 5 months . was documented.
Eris Therapeutics Private Limited was registered on 30 Jul 2009 with Roc Ahmedabad & aged 16 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Eris Therapeutics Private Limited is U24230GJ2009PTC057670.
Eris Therapeutics Private Limited is headquartered at Vision 2020, Sf-209, 150Ft Ring Road, Nr. Lijjat Papad, Plt-3-4,, Rajkot, Gujarat, 360007.
Eris Therapeutics Private Limited was incorporated on 30 July 2009.
The current directors of Eris Therapeutics Private Limited are
The primary industry of Eris Therapeutics Private Limited is Pharma.
Eris Therapeutics Private Limited is unlisted.
The authorized capital of Eris Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Eris Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX